Robert G. Josse mainly focuses on Internal medicine, Diabetes mellitus, Endocrinology, Osteoporosis and Surgery. His Internal medicine study combines topics from a wide range of disciplines, such as Placebo and Type 2 diabetes. His study explores the link between Diabetes mellitus and topics such as Insulin that cross with problems in Meal.
He has included themes like Crossover study and Carbohydrate in his Endocrinology study. His Osteoporosis research incorporates themes from Vitamin D and neurology, Physical therapy, Incidence and Gerontology. His biological study spans a wide range of topics, including Osteonecrosis of the jaw, Bisphosphonate-associated osteonecrosis of the jaw and Hazard ratio.
His primary areas of study are Internal medicine, Endocrinology, Osteoporosis, Diabetes mellitus and Type 2 diabetes. His study on Internal medicine is mostly dedicated to connecting different topics, such as Acarbose. As a part of the same scientific study, he usually deals with the Endocrinology, concentrating on Carbohydrate and frequently concerns with Food science.
His Osteoporosis research is multidisciplinary, incorporating elements of Physical therapy and Surgery. His work deals with themes such as Prospective cohort study, Hip fracture, Risk factor and Confidence interval, which intersect with Physical therapy. He regularly links together related areas like Placebo in his Diabetes mellitus studies.
His primary areas of investigation include Internal medicine, Osteoporosis, Type 2 diabetes, Diabetes mellitus and Endocrinology. His study connects Gastroenterology and Internal medicine. His Osteoporosis research incorporates elements of Physical therapy and Surgery.
His research in Type 2 diabetes intersects with topics in Blood lipids, Disease, Blood pressure and Risk factor. His work in Diabetes mellitus addresses subjects such as Ginseng, which are connected to disciplines such as Clinical endpoint. He has researched Endocrinology in several fields, including Cohort study and Animal science.
Robert G. Josse mostly deals with Internal medicine, Osteoporosis, Type 2 diabetes, Diabetes mellitus and Endocrinology. The study incorporates disciplines such as Surgery and Plant protein in addition to Internal medicine. The concepts of his Osteoporosis study are interwoven with issues in Bone remodeling and Intensive care medicine.
His Type 2 diabetes research focuses on subjects like Gastroenterology, which are linked to Relative risk and Pancreatic cancer. His specific area of interest is Diabetes mellitus, where Robert G. Josse studies Glycemic. When carried out as part of a general Endocrinology research project, his work on Blood pressure is frequently linked to work in Context, therefore connecting diverse disciplines of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson;Robert G Josse;Ramon Gomis;Markolf Hanefeld.
The Lancet (2002)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B Green;M. Angelyn Bethel;Paul W Armstrong;John B Buse.
The New England Journal of Medicine (2015)
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
Jean-Louis Chiasson;Robert G. Josse;Ramon Gomis;Markolf Hanefeld.
Global vitamin D status and determinants of hypovitaminosis D.
A. Mithal;D. A. Wahl;Jean-Philippe Bonjour;P. Burckhardt.
Osteoporosis International (2009)
The glycemic index: methodology and clinical implications
T. M. S. Wolever;D. J. A. Jenkins;A. L. Jenkins;R. G. Josse.
The American Journal of Clinical Nutrition (1991)
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Aliya A Khan;Archie Morrison;David A Hanley;Dieter Felsenberg.
Journal of Bone and Mineral Research (2015)
IOF position statement: vitamin D recommendations for older adults
B. Dawson-Hughes;A. Mithal;J.P. Bonjour;S. Boonen.
Osteoporosis International (2010)
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
J D Adachi;W G Bensen;J Brown;D Hanley.
The New England Journal of Medicine (1997)
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein
David J. A. Jenkins;Cyril W. C. Kendall;Augustine Marchie;Dorothea A. Faulkner.
The Efficacy of Acarbose in the Treatment of Patients with Non–Insulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial
J L Chiasson;R G Josse;J A Hunt;C Palmason.
Annals of Internal Medicine (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: